Gene Therapies and Stem Cells: The Future of Dry AMD Treatment Dry Age-Related Macular Degeneration Market
The Dry Age-Related Macular Degeneration (AMD) market is witnessing a surge in activity driven by advancements in dry macular degeneration treatment options. As the population ages, the prevalence of AMD, particularly the dry form, continues to rise, presenting a significant unmet medical need. This has spurred intensive research and...